NanoVation provides monitoring solutions for patients with chronic respiratory diseases. NanoVation detects respiratory changes before reaching critical stages. Their aim is to improve the outcomes of patient's respiratory deteriorations by enabling early identification and intervention at home. Their patented technology can identify subtle changes in patient's respiratory condition, enabling healthcare professionals to take proactive measures and prevent patient’s exacerbations and unnecessary hospitalizations. NanoVation was founded by Gregory Shuster.